A case of Guillain–Barre syndrome following Pfizer COVID-19 vaccine

Since the first-reported case of Severe Acute Respiratory Distress Syndrome-Coronavirus 2 in December 2019, COVID-19 has caused a global pandemic associated with significant morbidity and mortality. After a year of advances in vaccine research and development, three vaccines for the prevention of CO...

Full description

Bibliographic Details

Published in:	Journal of Community Hospital Internal Medicine Perspectives
Main Authors:	Shiavax J. Rao, Sahiba Khurana, Gayathri Murthy, Elliot T. Dawson, Noushin Jazebi, Christopher J. Haas
Format:	Article
Language:	English
Published:	Greater Baltimore Medical Center 2021-09-01
Subjects:	guillain barre syndrome coronavirus covid-19 vaccination pfizer
Online Access:	http://dx.doi.org/10.1080/20009666.2021.1954284